NervGen Pharma Corp. is a regenerative medicine company dedicated to the advancement of innovative therapeutics for the treatment of nerve damage, The company is developing revolutionary technologies that promote nerve regeneration in a range of applications including spinal cord injuries ("SCI") and peripheral nerve injuries ("PNI"). The company is also identifying, evaluating and considering development of other drug candidates for other medical conditions arising from nerve damage.